MedDataX Logo

Effectiveness of an Observational Unit at St. Olavs Hospital

NCT ID: NCT01092234

Last Updated: 2017-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The trial is designed to evaluate the effectiveness of a newly established Observational unit at St. Olavs Hospital in terms of readmission rates, compared to the provision of care in normal/traditional units for defined diagnosis and medical problems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Observational units are thought to be more efficient than traditional ward units, but the evidence is scarce. The trial will in a randomized fashion evaluate the study hypothesis at an organizational level and not confined to specific diagnosis. The hypothesis to be tested is to confirm or reject the equal effectiveness of an Observational unit compared to a traditional ward for organizing in-hospital care.There are established eligibility and exclusion criteria based on clinical experience. Endpoint is length of stay and readmission within 30 days. In addition the study will give information on the use of diagnostic and treatment resources used and collect some basic demographic variables.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergency Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Traditional ward

Group Type ACTIVE_COMPARATOR

Traditional ward

Intervention Type OTHER

provision of care in a traditional unit/ward.

Observational unit

Organizational change. Innovative organization of in-hospital care

Group Type EXPERIMENTAL

Organizational change

Intervention Type OTHER

Observational unit (new organizational unit) for organizing in-hospital care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traditional ward

provision of care in a traditional unit/ward.

Intervention Type OTHER

Organizational change

Observational unit (new organizational unit) for organizing in-hospital care

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Healthcare innovation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Emergency admitted patients only
* All patients on the list (appendix 1) with a tentative length of stay \< 24 hours
* Predicted stay of less than 24 hours
* Willingness and able to sign a informed consent

Exclusion Criteria

* Emergency admitted patients with life threatening illnesses
* Patients with a tentative length of stay \> 24 hours based on the summary of medical and logistical considerations e.g. need of major - surgery, infections with prolonged infusions of antibiotics.
* Unwillingness to sign a informed consent
* By discretion of the physician/surgeon
* Readmission of any reason in the study period (within 30 days)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Olavs Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Erik Rødevand, MD

Role: PRINCIPAL_INVESTIGATOR

St. Olavs Hospital

Siv Mørkved, Professor

Role: STUDY_CHAIR

St. Olavs Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Olavs Hospital

Trondheim, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NO883974832

Identifier Type: OTHER

Identifier Source: secondary_id

2010/105-02

Identifier Type: -

Identifier Source: org_study_id